Public believe China and India set to become World leaders for innovation
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
Rituxan/MabThera decreased the risk of needing later treatment with chemotherapy or radiotherapy by 80%
- Details
- Category: Roche
![Roche Roche](/images/stories/logo/roche.gif)
Amgen's Nplate(R) Maintains Platelet Counts for More Than Five Years in Adults with Chronic ITP
- Details
- Category: Amgen
![Amgen Inc. Amgen Inc.](/images/stories/logo/amgen.gif)
Commitment of Novartis in advancing treatments for patients with cancer and rare diseases
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
Genzyme Completes Sale of Genetic Testing Business to LabCorp
- Details
- Category: Genzyme
![Genzyme Genzyme](/images/stories/logo/genzyme.gif)
Bristol-Myers Squibb and Alvin Ailey American Dance Theater Announce First-of-Its-Kind Collaboration
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
GlaxoSmithKline to increase its shareholding in Theravance
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline GlaxoSmithKline](/images/stories/logo/gsk.gif)
More Pharma News ...
- GlaxoSmithKline and JSC Binnopharm enter vaccine production alliance in Russia
- Merck KGaA Announces Extension of FDA Priority Review Period for Cladribine Tablets
- Abbott Named One of the Top 10 Companies in Calvert Diversity Survey
- Roche obtains license for EGFR lung cancer assays and will develop Tarceva companion diagnostic test
- Bayer and Regeneron Report Positive Top-Line Results of Two Phase 3 Studies with VEGF Trap-Eye
- Abbott Announces Positive Results from Phase 2 Study of Low Dose Atrasentan for Treatment of Diabetic Kidney Disease
- APPRAISE-2 Study with Investigational Compound Apixaban Discontinued